OBI-858
- Generic Name
- OBI-858
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
Phase 1
- Conditions
- Parkinson DiseaseParkinsonismSeborrheic Dermatitis
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2008-10-07
- Lead Sponsor
- Rabin Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00767546
Botulinum Toxin for Carpal Tunnel Syndrome
Phase 2
Withdrawn
- Conditions
- Carpal Tunnel Syndrome
- Interventions
- Drug: Corticosteroid injection into Carpal Tunnel
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2019-04-17
- Lead Sponsor
- University of Minnesota
- Registration Number
- NCT00701233
- Locations
- 🇺🇸
University of Minnesota PM&R Department, Minneapolis, Minnesota, United States
Botulinum Toxin Injection for Treatment of Vaginismus
- First Posted Date
- 2008-03-18
- Last Posted Date
- 2008-03-18
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT00638066
- Locations
- 🇮🇷
Tehran University of Medical Sciences, Vali e Asr Reproductive Health Research Center, Tehran, Iran, Islamic Republic of
Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-03-13
- Lead Sponsor
- Norwegian University of Science and Technology
- Target Recruit Count
- 28
- Registration Number
- NCT00184197
- Locations
- 🇳🇴
Dept. of Neurology and Clinical Neurophysiology, Norwegian Headache Centre, Trondheim, Norway
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
Phase 2
Completed
- Conditions
- Cerebral Palsy
- First Posted Date
- 2005-08-24
- Last Posted Date
- 2008-07-04
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 23
- Registration Number
- NCT00133861
- Locations
- 🇫🇷
Hôpital Edouard Herriot - Pavillon T bis, Lyon, France
Botox on Vulvar Vestibulitis
Phase 4
- Conditions
- Vulvar DiseasesVulvar Vestibulitis
- First Posted Date
- 2005-07-14
- Last Posted Date
- 2007-04-19
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 64
- Registration Number
- NCT00119886
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath